Monograph Details
|
|
Immune System
> Immunization
|
|
MENOMUNE-A/C/Y/W-135 |
| Manufacturer |
|
Sanofi Pasteur, Inc. |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Neisseria meningitidis polysaccharides 50micrograms; each of Group A, C, Y, and W-135 per 0.5mL; pwd for SC inj after reconstitution. |
| Indications |
|
Meningitis immunization. |
| Adults and Children |
|
<2 years: not recommended (except as short-term protection in infants ≥3 months of age against Group A). ≥2 years: 0.5 mL SC once. If still at high risk, may revaccinate children first vaccinated at <4 years of age after 2–3 years, and older children and adults after 3–5 years. |
| Contraindications |
|
Acute illness. |
| Precautions |
|
Immunodeficiency. Have epinephrine inj (1:1000) available. Latex allergy. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Do not give with whole-cell pertussis or whole-cell typhoid vaccines. Immunosuppressants: may get suboptimal response. |
| Adverse Reactions |
|
Tenderness, erythema, or pain at inj site; headache, malaise, chills, fever. |
| How Supplied |
Single-dose vials—1, 5 (preservative-free diluent)
Multidose vial—1 (thimerosal-preserved diluent) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
